Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
220.02
Dollar change
-2.22
Percentage change
-1.00
%
IndexS&P 500 P/E37.04 EPS (ttm)5.94 Insider Own0.17% Shs Outstand289.10M Perf Week-0.85%
Market Cap62.98B Forward P/E13.99 EPS next Y15.73 Insider Trans-0.36% Shs Float288.63M Perf Month-8.35%
Income1.73B PEG4.29 EPS next Q2.98 Inst Own90.60% Short Float0.73% Perf Quarter-7.25%
Sales20.18B P/S3.12 EPS this Y9.73% Inst Trans0.92% Short Ratio1.47 Perf Half Y-8.57%
Book/sh89.55 P/B2.46 EPS next Y9.11% ROA3.14% Short Interest2.11M Perf Year-5.75%
Cash/sh8.04 P/C27.37 EPS next 5Y8.63% ROE6.68% 52W Range218.75 - 249.89 Perf YTD-9.76%
Dividend Est.3.88 (1.76%) P/FCF20.49 EPS past 5Y8.27% ROI3.88% 52W High-11.95% Beta0.41
Dividend TTM3.80 (1.73%) Quick Ratio0.74 Sales past 5Y4.72% Gross Margin45.36% 52W Low0.58% ATR (14)3.81
Dividend Ex-DateDec 09, 2024 Current Ratio1.17 EPS Y/Y TTM19.34% Oper. Margin14.29% RSI (14)35.16 Volatility1.26% 1.91%
Employees74000 Debt/Eq0.81 Sales Y/Y TTM4.16% Profit Margin8.55% Recom1.44 Target Price276.54
Option/ShortYes / Yes LT Debt/Eq0.72 EPS Q/Q292.60% Payout64.86% Rel Volume1.94 Prev Close222.24
Sales Surprise1.06% EPS Surprise1.12% Sales Q/Q6.88% EarningsNov 07 BMO Avg Volume1.44M Price220.02
SMA20-2.24% SMA50-5.57% SMA200-6.38% Trades Volume2,793,363 Change-1.00%
Date Action Analyst Rating Change Price Target Change
Oct-01-24Upgrade Citigroup Neutral → Buy $255 → $275
May-30-24Initiated Goldman Buy $274
Jul-24-23Upgrade Raymond James Mkt Perform → Outperform $305
May-30-23Resumed Morgan Stanley Overweight $295
May-05-23Upgrade Piper Sandler Neutral → Overweight $260 → $290
Apr-12-23Upgrade KeyBanc Capital Markets Sector Weight → Overweight $304
Jan-03-23Upgrade BofA Securities Neutral → Buy $250 → $290
Dec-12-22Upgrade Citigroup Sell → Neutral $221 → $250
Jul-11-22Downgrade Citigroup Neutral → Sell $265 → $235
Jun-24-22Upgrade Wells Fargo Equal Weight → Overweight $275
Dec-05-24 04:05PM
Dec-02-24 02:21PM
Nov-26-24 01:15PM
Nov-20-24 02:15PM
Nov-19-24 04:15PM
01:02PM Loading…
Nov-12-24 01:02PM
Nov-11-24 09:40AM
Nov-08-24 02:07AM
Nov-07-24 11:56PM
01:18PM
12:45PM
10:13AM
09:30AM
07:45AM
06:52AM
06:30AM Loading…
06:30AM
06:25AM
Nov-04-24 09:16AM
Nov-03-24 01:37PM
Oct-31-24 10:01AM
Oct-30-24 09:40AM
06:50AM
06:05AM
Oct-29-24 09:45AM
06:50AM
Oct-25-24 06:53AM
Oct-22-24 12:45PM
Oct-15-24 05:07AM
Oct-14-24 09:40AM
06:45AM
12:10PM Loading…
Oct-11-24 12:10PM
09:45AM
Oct-10-24 07:21PM
04:15PM
Oct-07-24 09:50AM
Oct-03-24 05:05PM
Oct-02-24 05:00PM
08:40AM
Sep-26-24 06:50AM
Sep-25-24 04:05PM
Sep-18-24 06:50AM
Sep-10-24 09:40AM
Sep-09-24 09:45AM
Sep-04-24 05:32AM
Sep-03-24 04:30PM
04:30PM
Aug-23-24 09:45AM
Aug-22-24 01:00PM
09:40AM
Aug-21-24 09:50AM
Aug-15-24 10:57AM
Aug-13-24 03:01PM
Aug-12-24 06:50AM
Aug-08-24 04:15PM
07:00AM
Aug-06-24 04:20PM
Aug-03-24 01:04AM
Aug-01-24 01:43PM
12:57PM
09:30AM
07:45AM
06:39AM
06:30AM
Jul-30-24 05:30AM
Jul-29-24 12:17PM
09:16AM
Jul-25-24 06:45AM
Jul-23-24 04:15PM
12:00PM
Jul-19-24 08:58AM
Jul-16-24 12:19PM
Jul-11-24 03:45PM
Jul-10-24 12:12PM
06:50AM
Jul-05-24 12:08PM
Jul-04-24 04:12AM
Jul-03-24 08:30AM
Jul-01-24 06:00AM
Jun-27-24 12:51PM
Jun-26-24 06:45AM
Jun-22-24 07:27AM
07:20AM
Jun-20-24 08:30AM
Jun-10-24 07:01AM
Jun-06-24 02:31PM
02:25PM
Jun-05-24 12:18PM
Jun-04-24 04:45AM
Jun-03-24 04:30PM
02:13PM
11:58AM
11:34AM
08:25AM
06:30AM
06:30AM
May-21-24 04:30PM
May-17-24 12:27PM
May-15-24 10:57AM
06:45AM
May-06-24 10:51AM
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shan DavidEVP and Chief ISC OfficerDec 05 '24Sale220.251,500330,3756,285Dec 06 04:55 PM
ROLAND GOETTEOfficerDec 06 '24Proposed Sale222.244,483996,302Dec 06 04:31 PM
SHANA NEALOfficerDec 06 '24Proposed Sale222.241,000222,240Dec 06 04:31 PM
DAVID SHANOfficerDec 05 '24Proposed Sale221.431,500332,145Dec 05 04:42 PM
BURZIK CATHERINE MDirectorSep 16 '24Proposed Sale235.7840094,312Sep 16 11:52 AM
Goette RolandEVP and President EMEAAug 14 '24Option Exercise132.545,295701,79916,603Aug 15 01:47 PM
Spoerel Thomas JSVP,Controller&Chief Acct OffJun 10 '24Sale239.3130071,7931,976Jun 11 01:45 PM
Goette RolandEVP and President EMEAMay 15 '24Sale236.733,300781,22411,308May 16 07:54 PM
Goette RolandEVP and President EMEAMay 13 '24Sale236.703,300781,12114,608May 15 02:44 PM
Garrison Michael DavidEVP & President MedicalApr 30 '24Sale232.811,715399,2695,381May 01 12:59 PM
Spoerel Thomas JSVP,Controller&Chief Acct OffMar 14 '24Sale238.2928267,1982,276Mar 15 02:19 PM
Garrison Michael DavidEVP & President MedicalDec 11 '23Sale232.461,239288,0187,274Dec 12 04:31 PM